'I can get more time': Breast cancer patient finds out she can get life extending drug

'I can get more time': Breast cancer patient finds out she can get life extending drug Patients in England with a particular form of incurable breast cancer can now obtain a life‑extending drug via the NHS. The medication, Enhertu, offers roughly seven extra months of survival on average. Women in Scotland have been able to receive the treatment through the NHS since 2023, and it is licensed in 26 other European nations. Clinicians in England are presently authorised to prescribe it; Wales is anticipated to follow shortly, though the guidance does not automatically extend to Northern Ireland. Kate Wills, 51, who lives with HER2‑low metastatic breast cancer that has spread to her bones and lungs, reacted with tears upon learning the drug would be funded by the NHS. She stated, "I truly can't judge it. I'm truthful relieved, I'm overjoyed," she says. She also remarked, "It's truthful hard keeping anticipation erstwhile you person signifier 4 cancer. This gives maine tremendous hope."